THE NEED Despite the overall good prognosis of luminal breast cancers, risk of recurrence rises substantially if the cancer had already metastasized to nearby lymph nodes by the time of diagnosis. While lymph node negative patients may benefit from endocrine therapy alone, the standard of care ...